This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Canine Flu Therapeutics Market

Therapeutics Are Robustly Steering Their Way Through the Prevailing Canine Influenza Amongst Dogs: Key Insights By FMI

Canine Flu Therapeutics Market by Drug Class, Distribution Channel & Region - Forecast 2022 - 2032

Canine Flu Therapeutics Market Outlook (2022-2032)

[342 Pages Report] The canine flu therapeutics market is projected to have a slow-paced CAGR of 4.1% during the forecast period. The current valuation of the canine flu therapeutics market is US$ 1975.4 million in 2022. The market value of the canine flu therapeutics market is anticipated to reach a high of US$ 3067.8 million by the year 2032. A historical CAGR of 3.8% has been recorded by the experts of Future Market Insights for the concerned market.

It has been identified in while analysis that canine flue is segmented into two types and they are H3N8 viruses and H3N2 (Seasonal influenza A) virus.

Report Attribute

Details

Canine Flu Therapeutics Market Value (2022)

US$ 1975.4 Million

Canine Flu Therapeutics Market Anticipated Value (2032)

US$ 3067.8 Million

Canine Flu Therapeutics Projected Growth Rate (2022-2032)

4.1%

Almost all dogs are susceptible to canine flu with direct contact or with respiratory discharges from infected dogs. The symptoms of illness are eye discharges, upper respiratory illness, reduced appetite, runny nose, cough, fever, and lethargy.

Moreover, the severity of canine flu ranges from no symptoms to terminal illness resulting in pneumonia and sometimes death. Therefore, the canine flu therapeutics market is likely to have significant growth during the forecast period and more adoption by dog owners to reduce the spread of flu and infections.

Customize this Report

Let us know your requirement to get
100% FREE customization

Demand Drivers Affecting the Growth of the Canine Flu Therapeutics Market

A number of factors have been identified by the experts of FMI while analyzing the canine flu therapeutics in depth that are propelling the market growth at a moderate pace. They are as follows:

  • Rising Diseases

A robust increase in the incidences of diseases with no specific treatment is likely to boost the canine flu therapeutics market expansion.

  • Innovation

The innovators in the market are getting the advantage of a monopolistic market as there is less competition across the globe.

  • Government Support

Increasing government support and rising research and development activities by the manufacturers are likely to foster the growth of the canine flu therapeutics market in the coming years.

  • Cost-effectiveness

Rapid turnaround time and lower cost of the procedures as compared to conventional methods are fueling the demand for canine flu therapeutics in the canine influenza treatment market.

Factors Deterring the Market Expansion of Canine Flue Therapeutics

Although key demand drivers have been identified in the canine flu therapeutics market, it is also witnessed that certain aspects are likely to hinder the growth and further slowdown the pace of expansion for the concerned market. The curbing factors are as follows:

  • Lack of Expertise

Lack of awareness and absence of trained professionals in the developing and underdeveloped economies may impede the propulsion of the canine flu therapeutics market.

  • Vaccine Limitations

The global market for canine flu therapeutics is expected to be deterred by a limited number of vaccines available in the market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Regional Outlook

How is the North America Canine Flue Therapeutics Market Performing?

North America is projected to hold the highest market share of canine flu therapeutics and is anticipated to dominate the market during the forecast period. Currently, the North American regions are cumulatively holding 37.6% of the total market share for canine flu therapeutics.

The market size in North America is expanding owing to factors like:

  • Rising infection rates have been recorded in pet dogs in North America.
  • There is increased awareness of the disease and its treatment with diagnostic methods that are further bolstering the demand for canine flu therapeutics in this region.

Growth Outlook of Europe Canine Flu Therapeutics Market

Europe is anticipated to hold the second largest share in the global canine flue therapeutics market, and have substantial growth over the forecast period. At present, the European region is accountable for 25.3% of the total market share of canine flu therapeutics.

The marker size expansion in Europe can be attributed to the following factors:

  • Increasing animal adoption and rising consumer spending on veterinarian services due to the rise of disposable income in the European regions is driving the growth of the canine flu market.
  • The technological advancement in the healthcare sector in the region and expanding veterinary healthcare infrastructure are expected to augment the canine flu therapeutics market.

Start-Up Ecosystem

New Entrants Ardently Performing in the Canine Flu Therapeutics Market

According to the research study conducted by FMI, the new entrants in the canine flu therapeutics market are continually indulging in several collaborations and highly investing in research and development activities to provide more effective therapeutic solutions to dog owners, which would cure influenza faster and reduce the spread.

Zoetis is a start-up company that is lining up rival vaccines to fight a new strain of dog flu. The new vaccines don't protect against the previously known strain of dog flu, even though that illness is still circulating. So, dog owners who want total protection will have to get separate vaccines for H3N8 and H3N2.

Schering-Plough Animal Health is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products and is likely to have an impact on the therapeutics market in the coming years.

Some of the other start-ups proliferating in the market are Wiggles, Fidocure, Itch., Nexvet, Hesterbiosciences, and Gallant.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

Market Players to Fuel Further Growth in the Canine Flu Therapeutics Market

Attributed to the presence of such a high number of participants, the market is highly competitive. The key players are adopting several growth strategies and finding means o upgrade the vaccines that can cure influenza in animals faster and in a more cost-effective way.

Recent Developments

  • In August 2021, Merck Animal Health announced new naming for its cattle vaccine portfolio; one of the largest and most comprehensive vaccine portfolios in the industry. The goal of the new naming and packaging is to make it easier for customers to recognize the company’s vaccines and to identify specific formulations.
  • In November 2020, Merck announced it had received a conditional license from the USDA to market Canine Influenza Vaccine H3N2--just one week after Zoetis received the same USDA nod for its vaccine. Both of the new vaccines require two doses, administered a few weeks apart.
  • In October 2018, the European Clinical Office has given the approval to utilize Serological hemagglutination hindrance (HI) for flu testing.

Some of the key players in the canine flu therapeutics market are:

  • Interver Inc
  • Merck Animal Health
  • al Health
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Pfizer Inc.
  • Boehringer Ingelheim International GmbH
  • Sanofi
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 4.1% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Drug Class
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Interver Inc
  • Merck Animal Health
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Pfizer Inc.
  • Boehringer Ingelheim International GmbH
  • Sanofi
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.

Customization

Available Upon Request

Key Segments in the Canine Flu Therapeutics Market

By Drug Class:

  • Antibiotics
  • Nonsteroidal anti-inflammatory Drugs (NSAIDs)
  • Antiviral Drugs

By Distribution Channel:

  • Veterinary Clinics
  • Veterinary Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The growth outlook for the canine flue therapeutics market is predicted to advance at a CAGR of 4.1% from 2022-to 2032.

The North American region is anticipated to lead the canine flue therapeutics market during the forecast period.

The canine flue therapeutics market is likely to hold a valuation of US$ 3067.8 million by 2032.

The animal healthcare sector is the key driver in the canine flue therapeutics market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Canine Flu Therapeutics Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Canine Flu Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032

        5.3.1. Vaccines

        5.3.2. Antibiotics

        5.3.3. Anti-Inflammatory Drugs

        5.3.4. Others

    5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Type, 2022-2032

6. Global Canine Flu Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        6.3.1. Veterinary Hospitals

        6.3.2. Vet Clinics

        6.3.3. Animal Healthcare Facilities

    6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Canine Flu Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Canine Flu Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. US

            8.2.1.2. Canada

        8.2.2. By Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Canine Flu Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Canine Flu Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By End User

    10.4. Key Takeaways

11. Asia Pacific Canine Flu Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Rest of Asia Pacific

        11.2.2. By Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By End User

    11.4. Key Takeaways

12. MEA Canine Flu Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By End User

    12.4. Key Takeaways

13. Key Countries Canine Flu Therapeutics Market Analysis

    13.1. US

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Type

            13.1.2.2. By End User

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Type

            13.2.2.2. By End User

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Type

            13.3.2.2. By End User

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Type

            13.4.2.2. By End User

    13.5. Germany

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Type

            13.5.2.2. By End User

    13.6. U.K.

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Type

            13.6.2.2. By End User

    13.7. France

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Type

            13.7.2.2. By End User

    13.8. Spain

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Type

            13.8.2.2. By End User

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Type

            13.9.2.2. By End User

    13.10. China

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Type

            13.10.2.2. By End User

    13.11. Japan

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Type

            13.11.2.2. By End User

    13.12. South Korea

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Type

            13.12.2.2. By End User

    13.13. GCC Countries

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Type

            13.13.2.2. By End User

    13.14. South Africa

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Type

            13.14.2.2. By End User

    13.15. Israel

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Type

            13.15.2.2. By End User

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Type

        14.3.3. By End User

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Merck & Co

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Zoetis Services LLC

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. GlaxoSmithKline

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Pfizer

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Novartis

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. Sanofi

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Boehringer Ingelheim International

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Bristol-Myers Squibb

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. Roche

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. Eli Lilly and Company

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

        15.1.11. Abbott Laboratories

            15.1.11.1. Overview

            15.1.11.2. Product Portfolio

            15.1.11.3. Profitability by Market Segments

            15.1.11.4. Sales Footprint

            15.1.11.5. Strategy Overview

                15.1.11.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 3: Global Canine Flu Therapeutics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 4: North America Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 5: North America Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 6: North America Canine Flu Therapeutics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 7: Latin America Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Latin America Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 9: Latin America Canine Flu Therapeutics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 10: Europe Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 12: Europe Canine Flu Therapeutics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: Asia Pacific Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 15: Asia Pacific Canine Flu Therapeutics Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: MEA Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: MEA Canine Flu Therapeutics Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 18: MEA Canine Flu Therapeutics Market Value (US$ Mn) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Canine Flu Therapeutics Market Value (US$ Mn) by Type, 2022-2032

Figure 2: Global Canine Flu Therapeutics Market Value (US$ Mn) by End User, 2022-2032

Figure 3: Global Canine Flu Therapeutics Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 5: Global Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 8: Global Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 9: Global Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 10: Global Canine Flu Therapeutics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 11: Global Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 12: Global Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 13: Global Canine Flu Therapeutics Market Attractiveness by Type, 2022-2032

Figure 14: Global Canine Flu Therapeutics Market Attractiveness by End User, 2022-2032

Figure 15: Global Canine Flu Therapeutics Market Attractiveness by Region, 2022-2032

Figure 16: North America Canine Flu Therapeutics Market Value (US$ Mn) by Type, 2022-2032

Figure 17: North America Canine Flu Therapeutics Market Value (US$ Mn) by End User, 2022-2032

Figure 18: North America Canine Flu Therapeutics Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 23: North America Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 24: North America Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 25: North America Canine Flu Therapeutics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 26: North America Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 27: North America Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 28: North America Canine Flu Therapeutics Market Attractiveness by Type, 2022-2032

Figure 29: North America Canine Flu Therapeutics Market Attractiveness by End User, 2022-2032

Figure 30: North America Canine Flu Therapeutics Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Canine Flu Therapeutics Market Value (US$ Mn) by Type, 2022-2032

Figure 32: Latin America Canine Flu Therapeutics Market Value (US$ Mn) by End User, 2022-2032

Figure 33: Latin America Canine Flu Therapeutics Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 38: Latin America Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 39: Latin America Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 40: Latin America Canine Flu Therapeutics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 41: Latin America Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: Latin America Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: Latin America Canine Flu Therapeutics Market Attractiveness by Type, 2022-2032

Figure 44: Latin America Canine Flu Therapeutics Market Attractiveness by End User, 2022-2032

Figure 45: Latin America Canine Flu Therapeutics Market Attractiveness by Country, 2022-2032

Figure 46: Europe Canine Flu Therapeutics Market Value (US$ Mn) by Type, 2022-2032

Figure 47: Europe Canine Flu Therapeutics Market Value (US$ Mn) by End User, 2022-2032

Figure 48: Europe Canine Flu Therapeutics Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 53: Europe Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 54: Europe Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 55: Europe Canine Flu Therapeutics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 56: Europe Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 57: Europe Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 58: Europe Canine Flu Therapeutics Market Attractiveness by Type, 2022-2032

Figure 59: Europe Canine Flu Therapeutics Market Attractiveness by End User, 2022-2032

Figure 60: Europe Canine Flu Therapeutics Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Canine Flu Therapeutics Market Value (US$ Mn) by Type, 2022-2032

Figure 62: Asia Pacific Canine Flu Therapeutics Market Value (US$ Mn) by End User, 2022-2032

Figure 63: Asia Pacific Canine Flu Therapeutics Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 68: Asia Pacific Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 69: Asia Pacific Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 70: Asia Pacific Canine Flu Therapeutics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 71: Asia Pacific Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 72: Asia Pacific Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 73: Asia Pacific Canine Flu Therapeutics Market Attractiveness by Type, 2022-2032

Figure 74: Asia Pacific Canine Flu Therapeutics Market Attractiveness by End User, 2022-2032

Figure 75: Asia Pacific Canine Flu Therapeutics Market Attractiveness by Country, 2022-2032

Figure 76: MEA Canine Flu Therapeutics Market Value (US$ Mn) by Type, 2022-2032

Figure 77: MEA Canine Flu Therapeutics Market Value (US$ Mn) by End User, 2022-2032

Figure 78: MEA Canine Flu Therapeutics Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: MEA Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Canine Flu Therapeutics Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 83: MEA Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 84: MEA Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 85: MEA Canine Flu Therapeutics Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 86: MEA Canine Flu Therapeutics Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 87: MEA Canine Flu Therapeutics Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 88: MEA Canine Flu Therapeutics Market Attractiveness by Type, 2022-2032

Figure 89: MEA Canine Flu Therapeutics Market Attractiveness by End User, 2022-2032

Figure 90: MEA Canine Flu Therapeutics Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Peptide Therapeutics Market

Published : February 2022

Healthcare

Lung Cancer Therapeutics Market

Published : February 2022

Healthcare

Leukemia Therapeutics Treatment Market

Published : February 2022

Google translate

Canine Flu Therapeutics Market